company-intro – SCI Korea

Company

CEO Greeting | Philosophy | Introduction

Introduction

We provide personalized health management services based on an IoT healthcare big data platform, utilizing pattern analysis and management of biometric data collected through BCG sensors.

Key Products

Biometric Measurement Device Manufacturing & Healthcare AI Solutions

Year of Establishment

APR. 11, 2016

CEO

Park Cheol Gu

Company Name

SCI Korea

History

SCI Korea delivers more creative and innovative services.

2024

Approval of Confirmatory Clinical Trial for Ballistocardiograph (BCG) Device

Non-Disclosure Agreement (NDA) with AMWAY

Non-Disclosure Agreement (NDA) with CELLATTI

2020-01-01

2023

Selected for an R&D Project under the Research and Development Special Zone Promotion Program

Selected for the Deep Tech TIPS Program (KRW 1.5 billion over 3 years)

Analytical Researcher-Initiated Clinical Study on a PPG-Based Blood Glucose Monitoring System

Venturenara Designation Certificate from the Public Procurement Service (EDL-1004)

Completion of Class II Exploratory Clinical Trial for a Ballistocardiograph (BCG) Device

KC Certification for a Non-Invasive AI Health Management Assistive Device

Patent Application Filed for a Pet Blood Glucose and Blood Pressure Measurement Device Using PPG Sensors

Patent Registered for a Blood Pressure Measurement Device Using Ballistocardiography and Artificial Intelligence Technologies

Label

2021 - 2022

Secured Investment from the Jeonnam Angel Investment Matching Fund

Patent Registered for a Fall Prediction Method Using a Ballistocardiography Sensor and Camera

ISO 13485 Quality Certification for Ballistocardiograph Devices and Healthcare Solutions

Patent Registered for a Method and System for Diabetes Prediction Using Ballistocardiography Signals

Patent Registered for a Method and System for Arrhythmia Prediction Using Ballistocardiography Signals

Patent Registered for a Method and System for Hypertension Prediction Using Machine Learning

Head Office Relocated (Jangseong → Gwangju)

Research Paper Published on Blood Glucose Level Prediction Using PPG and Machine Learning

Selected as a Kibo-Star Valley Company

2021-01-01

2019 - 2020

Selected for the Leading Startup R&D Project under the SME Technology Development Support Program (Ministry of SMEs and Startups)

KC Certification for a Single-Axis Ballistocardiography Sensor

Venture Company Certification (Korea Technology Finance Corporation, Kibo)

Quality Management System Certification (ISO 9001:2015)

Registered as a Research Institute Company

Selected for the 2020 Startup Growth Technology Development Program (Stepping Stone Program) by the Ministry of SMEs and Startups

Selected for the 2020 Startup Leap Package Support Program – “Majung” Track

Product Registration Application Filed for EDL-1004

Certified as a Corporate-Affiliated Research Institute

2021-01-01

2017 - 2018

Head Office Relocated (Gwangyang City → Jangseong County, Jeonnam)

Patent Registered for a Patient Management System Using Contactless Biometric Signal Measurement

Patent Registered for a Fall-Prevention Bed

Patent Registered for a Smart Pillow System

2021-01-01

2016

Established SCI Korea

Developed the EDL-1004 Pilot System

Private Policy

Company Name SCI Korea CEO Cheol Gu Park

Head Office
Room 205-2, Building 2 (Commercialization Center),
333 Cheomdangwagi-ro, Buk-gu, Gwangju 61008, Republic of Korea
Branch Office
Room 404, Building 2, Gwangju AI Startup Camp,
193-12 Geumnam-ro, Dong-gu, Gwangju 61472, Republic of Korea

Mail Order Business Registration No.: 2024-Gwangju Buk-gu-0441
Business Registration No.: 758-87-00323
Tel: +82-1600-0415
Email: pck3867@scikorea.co.kr